BioAtla (BCAB) Accounts Payables (2020 - 2026)
BioAtla (BCAB) recorded Accounts Payables of $19.45 million in Q2 2026, up 23.1% from $15.8 million a year earlier and up 1.7% from the prior quarter.
BioAtla (BCAB) Accounts Payables (2020 - 2026) Analysis & Trends
At the end of FY2025, BioAtla reported Accounts Payables of $16.35 million, up 19.3% from FY2024.
- Annual Accounts Payables has a five-year compound annual growth rate of 6.3% (FY2020 to FY2025).
- Across earlier years, Accounts Payables came in at $13.7 million in FY2024 (-48.7%), $26.72 million in FY2023 (+23.6%), $21.61 million in FY2022 (+17.3%) and $18.42 million in FY2021 (+52.7%).
- The Q2 2026 figure is the highest quarterly Accounts Payables since Q4 2023.
- On a year-over-year basis, Accounts Payables has increased for three consecutive quarters, with an average decline of 6.2% over the last eight quarters.
- Peak year-over-year performance for Accounts Payables in the last five years was growth of 56.9% in Q1 2023, against a decline of 50.8% in Q2 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $19.13 million (Q1 2026), $16.35 million (Q4 2025) and $16.81 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 9.22 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 3.83 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.58 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 429.50 Mn |
| 10 | BioAtla | 2.49 Mn | 2.49 Mn | - | 19.45 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19.45 Mn |
| Mar 31, 2026 | 19.13 Mn |
| Dec 31, 2025 | 16.35 Mn |
| Sep 30, 2025 | 16.81 Mn |
| Jun 30, 2025 | 15.80 Mn |
| Mar 31, 2025 | 15.45 Mn |
| Dec 31, 2024 | 13.70 Mn |
| Sep 30, 2024 | 18.21 Mn |
| Jun 30, 2024 | 15.80 Mn |
| Mar 31, 2024 | 17.75 Mn |
| Dec 31, 2023 | 26.72 Mn |
| Sep 30, 2023 | 34.01 Mn |
| Jun 30, 2023 | 32.08 Mn |
| Mar 31, 2023 | 24.71 Mn |
| Dec 31, 2022 | 21.61 Mn |
| Sep 30, 2022 | 22.33 Mn |
| Jun 30, 2022 | 24.03 Mn |
| Mar 31, 2022 | 15.75 Mn |
| Dec 31, 2021 | 18.42 Mn |
| Sep 30, 2021 | 24.94 Mn |
BioAtla Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=BCAB&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "BCAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=BCAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();